Cargando…
The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
Diabetes mellitus (DM) represents a major public health problem, with yearly increasing prevalence. DM is considered a progressive vascular disease that develops macro and microvascular complications, with a great impact on the quality of life of diabetic patients. Over time, DM has become one of th...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708213/ https://www.ncbi.nlm.nih.gov/pubmed/34945721 http://dx.doi.org/10.3390/jpm11121249 |